Inhibition of the transendothelial migration of human lymphocytes but not monocytes by phosphodiesterase inhibitors

Clinical and Experimental Immunology

Volumn 104, Issue 1, 1996, Pages 66-71

  Lidington, E ^a   Nohammer C ^a   Dominguez, M ^a   Ferry, B ^b   Rose, M L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

adhesion; endothelium; migration; phosphodiesterase

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ADULT; ARTICLE; CELL INTERACTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; MONOCYTE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL VEIN;

EID: 0029971803     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-660.x     Document Type: Article

References (20)

1. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991; 67:1033-6.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76:301-14.
3. 2. J Immunol 1994; 152:5703-13.
4. Derian CK, Santulli RJ, Rao PE et al. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators. J Immunol 1995; 154:308-17.
5. Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994; 7:579-91.
6. Kidney J, Dominguez M, Taylor PM et al. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151:1907-14.
7. Bird IN, Spragg JH, Ager A, Matthews N. Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunol 1993; 80:553-60.
8. Meerschaert J, Furie MB. Monocytes use either CD11/CD18 or VLA/4 to migrate across human endothelium in vitro. J Immunol 1994; 152:1915-26.
9. Oppenheimer-Marks N, Davis LS, Tompkins Bogue D et al. Differential utilisation of ICAM-1 and VCAM-1 during the adhesion and transendothelial of human T lymphocytes. J Immunol 1991; 147:2913-21.
10. 1 integrin receptors for fibronectin α4β1 and α5β1. J Cell Sci 1992; 101:885-94.
11. Deisher TA, Garcia I, Harlan, JM. Cytokine-induced adhesion molecule expression on human umbilical vein endothelial cells is not regulated by cyclic adenosine monophosphate accumulation. Life Sci 1993; 53:365-70.
12. Pober JS, Slowik MR, De Luca LG et al. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993; 150:5114-23.
13. 2. Inflammation 1981; 5:81-87.
14. Freitas AA, Bognacki J. The role of cell locomotion in lymphocyte migration. Immunol 1979; 56:247-55.
15. Valitutti S, Dessing M, Lanzavecchia A. Role of cAMP in regulating cytotoxic T lymphocyte adhesion and motility. Eur J Immunol 1993; 23:790-5.
16. Stelzner TJ, Weil JV, O'Brien RF. Role of cyclic monophosphate in the induction of endothelial barrier properties. J Cell Physiol 1989; 139:157-66.
17. Huang AJ, Manning JE, Bandak TM et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 1993; 120:1371-80.
18. Hauzenberger D, Klominek J, Sundqvist K-G. Functional specialization of fibronectin-binding β1-integrins in T lymphocyte migration. J Immunol 1994; 153:960-71.
19. Robicsek AS, Blanchard DK, Djeu JY et al. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem Pharmacol 1991; 42:869-77.
20. Raeburn D, Karlsson J-A. Effects of iosenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea-pig airways in vivo. J Pharmacol Exp Ther 1993; 267:1147-52.